maternal clinical conditions (Althabe et al. 2009).
A randomised controlled, multicenter, noninferiority trial, held for 16 months in 16 health facilities in Argentina, Egypt, India, Kenya, Philippines, South Africa, Thailand and Uganda, aimed to assess whether CCT can be withdrawn from the active management of TSL without increasing the risk of serious bleeding.